Yotiao Antibodies

Santa Cruz Biotechnology features a diverse variety of Yotiao Antibodies for advanced research in neuroscience and muscle biology. Yotiao Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Yotiao, also known as the DLG1 protein, plays a critical role in organizing signaling complexes at the neuromuscular junction and is essential for synaptic stability and function. The involvement of Yotiao in the regulation of ion channels and receptors highlights its importance in maintaining proper muscle contraction and neuronal communication. Dysregulation of Yotiao has been implicated in various neuromuscular disorders, making it a significant target for research. Understanding Yotiao's molecular interactions and cellular distribution patterns can provide valuable information about neuromuscular junction development and maintenance. Investigating Yotiao expression patterns helps reveal its role in both healthy and diseased states. Research focusing on Yotiao contributes to our understanding of neuromuscular disorders and potential therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of neuromuscular biology and potential therapeutic interventions.